期刊文献+

喉癌中血管内皮生长因子C和微淋巴管密度的关系 被引量:3

Relationship of VEGF-C expression and lymphatic microvessel density with cervical lymph node metastasis in human laryngeal cancer
下载PDF
导出
摘要 目的分析血管内皮生长因子C(vascular endothelial growth factor C,VEGF-C)、微淋巴管密度与颈淋巴结转移的关系,以及VEGF-C的表达与微淋巴管密度的相关性。方法采用免疫组化SP法,检测47例喉癌组织及15例声带息肉中的VEGF-C的表达;检测47例喉癌组织、癌旁组织中的微淋巴管密度。结果VEGF-C在Ⅰ、Ⅱ、Ⅲ级病理分级的阳性率分别为55%、72.22%、88.89%,表达与肿瘤分化明显相关(P<0.05)。VEGF-C在淋巴结转移组和非转移组的阳性率分别为82.35%和60%,差异显著(P<0.05)。喉癌组织微淋巴管密度在淋巴结转移组与非转移组分别为15.38±5.68和10.41±4.23,差异非常显著(P<0.01)。结论VEGF-C的表达与喉癌组织微淋巴管密度及喉癌的淋巴结转移密切相关。 OBJECTIVE To analyze the relationship of VEGF-C expression, lymphatic microvessel density and cervical lymph node metastasis in human laryngeal cancer, as well as the relationship of VEGF-C expression and lymphatic microvessel density. METHODS VEGF-C expression and lymphatic microvessel density were detected in 47 laryngeal cancer tissues with SP immunohistochemical method. RESULTS The positive rates of VEGF-C in the Ⅰ、Ⅱ、Ⅲ pathological grade level were 55 %, 72.22 %, 88.89% respectively, and its expression was significantly correlated with tumor differentiation(P〈 0.05). The positive rates of VEGF-C in lymphatic metastasis group and non-metastasis group were 82.35 % and 60 % respectively, and it had significant difference (P 〈 0.05). Lymphatic microvessel density of the Laryngeal cancer tissue in lymph node metastasis group and nonmetastasis group were 15.38±5.68 and 10.41 ±4.23 respectively, and it had significant difference (P 〈 0.01). CONCLUSION VEGF-C expression and the lymphatic microvessel density of the laryngeal cancer tissues are closely related to cervical lymph node metastasis.
出处 《中国耳鼻咽喉头颈外科》 北大核心 2008年第8期447-450,共4页 Chinese Archives of Otolaryngology-Head and Neck Surgery
关键词 喉肿瘤 肿瘤转移 免疫组化 血管内皮生长因子C 抗体 微淋巴管密度 Laryngeal Neoplasms Neoplasms Metastasis Immunohistochemistry Vascular Endothelial Growth Factor C Antibodies lymphatic microvessel density
  • 相关文献

参考文献7

  • 1[1]Fromowitz FB,Viola MV,Chao S,et al.Ras p21 expression in the progression of breast cancer.Hum Pathol,1987,18:1268-1275.
  • 2[2]Weidner N,Folkman J,Pozza F,et al.Tumor angiogenesis:a new significant and independent prognostic indicator in early-stage breast carcinoma.J Natl Cancer Inst,1992,84:1875-1887.
  • 3[3]Akagi K,Ikeda Y,Miyazaki M,et al.Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancertissues.Br J Cancer,2000,83:887-891.
  • 4[4]Skobe M,HawighorstT,Jackson DG,et al.Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.Nat Med,2001,7:192-198.
  • 5[5]Kaiserling E.Immunohistochemieal identification of lymph vessels,with D2-40 in diagnostic pathology.Pathology,2004,25:362-374,
  • 6[6]Van Den Eynden Gy,Van Der Auwera I,Van Laere SJ,et al.Distinguishing blood and lymph vessel invasion in breast cancer:a prospective immunohistochemical study.Br J Cancer,2006,94:1643-1649.
  • 7[7]Sedivy R,Beck-Mannagetta J,Haverkampf C,et al.Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer.J Oral Pathol Med,2003,32:455-460.

同被引文献24

  • 1Kaiserling E. Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology. Pathology, 2004, 25: 362-374.
  • 2Nakamura Y, Yasuoka H, Tsujimoto M, et al. FIt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Clin Cancer Res, 2003, 9: 5313-5317.
  • 3Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med, 2001, 7: 186-191.
  • 4Yokoyama Y, Chamock-Jones DS, Licence D, et al. Expression of vascular endothelial growth factor(VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res, 2003, 9: 1361-1369.
  • 5Hanrahan V, Currie M J, Gunningham SP, et al. The angiogenic switch for vascular endothelial growth factor (VEGF) -A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathoi, 2003, 200: 183-194.
  • 6Funaki H, Nishimura G, Harada S, et al. Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma. Oncology, 2003, 64: 416-422.
  • 7Marks A, Sutherland DR, Bailey D, et al. Characterization and distribution of an oncofetal antigen (M2Aantigen) expressed on testicular germ cell tumours. Br J Cancer, 1999, 80: 569-578.
  • 8Kahn H J, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcoma. Mod Pathol, 2002, 15: 434-440.
  • 9Peeters CF, Thomas CM, Sweep FC, et al. Elevated serum endothelin-1 levels in patients with colorectal cancer; relevance for prognosis. Int J Biol Markers, 2000, 15: 288-293.
  • 10Hinojar-Gutierrez A, Fernandez-Contreras ME, Gonzalez- Gonzalez R, et al. Intratumoral lymphatic vessels and VEGF-C expression are predictive factors of lymph node relapse in T1-T4 NO laryngopharyngeal squamous cell carcinoma. Ann Surg Oncol, 2007, 14: 248-257.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部